These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18160012)

  • 1. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
    Planque S; Mitsuda Y; Taguchi H; Salas M; Morris MK; Nishiyama Y; Kyle R; Okhuysen P; Escobar M; Hunter R; Sheppard HW; Hanson C; Paul S
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1541-54. PubMed ID: 18160012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
    Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
    J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41.
    Matsuda S; Noda M
    Microbiol Immunol; 2000; 44(11):923-9. PubMed ID: 11145273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
    Kozlowski PA; Chen D; Eldridge JH; Jackson S
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):813-22. PubMed ID: 7986587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
    Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
    Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120.
    Ponomarenko NA; Vorobiev II; Alexandrova ES; Reshetnyak AV; Telegin GB; Khaidukov SV; Avalle B; Karavanov A; Morse HC; Thomas D; Friboulet A; Gabibov AG
    Biochemistry; 2006 Jan; 45(1):324-30. PubMed ID: 16388609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite immune reactivity of serum IgG and secretory IgA to conformational recombinant proteins mimicking V1/V2 domains of three different HIV type 1 subtypes depending on glycosylation.
    Granados-Gonzalez V; Claret J; Berlier W; Vincent N; Urcuqui-Inchima S; Lucht F; Defontaine C; Pinter A; Genin C; Riffard S
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):289-99. PubMed ID: 18260782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA-mediated neutralization of HIV type 1.
    Burnett PR; VanCott TC; Polonis VR; Redfield RR; Birx DL
    J Immunol; 1994 May; 152(9):4642-8. PubMed ID: 8157978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.
    Sterjovski J; Churchill MJ; Ellett A; Wesselingh SL; Ramsland PA; Gorry PR
    Virology; 2012 Oct; 432(2):394-404. PubMed ID: 22818780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
    J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
    Boudet F; Theze J; Zouali M
    Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of conformation on the neutralizing antibody response to HIV-1 gp120.
    Steimer KS; Haigwood NL
    Biotechnol Ther; 1991; 2(1-2):63-89. PubMed ID: 1726963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
    Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
    AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic antibodies to HIV: physiological role and potential clinical utility.
    Planque S; Nishiyama Y; Taguchi H; Salas M; Hanson C; Paul S
    Autoimmun Rev; 2008 Jun; 7(6):473-9. PubMed ID: 18558365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies as defensive enzymes.
    Paul S; Nishiyama Y; Planque S; Karle S; Taguchi H; Hanson C; Weksler ME
    Springer Semin Immunopathol; 2005 Mar; 26(4):485-503. PubMed ID: 15633014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.